Advertisement
Comments Off
CVS/Caremark (NYSE: CVS) announced board approval of a stock repurchase plan of up to $5 billion. With approximately 1.6 billion shares outstanding and assuming that the company completes the program in 12 months, the repurchase yields $3.13 per share.
###
PAYOUT YIELD ANALYSIS
The annualized dividend of $0.24 plus the $3.13 per share from the repurchase program results […]